Analyst Price Targets — VTRS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 9, 2026 10:05 am | Ashwani Verma | UBS | $18.00 | $14.58 | TheFly | Viatris upgraded to Buy from Neutral at UBS |
| January 28, 2026 11:49 am | — | Piper Sandler | $12.00 | $13.12 | TheFly | Viatris price target raised to $12 from $9 at Piper Sandler |
| January 16, 2026 12:14 pm | — | Argus Research | $15.00 | $12.84 | TheFly | Argus upgrades Viatris to Buy on expected buybacks, debt reduction |
| January 7, 2026 12:22 pm | Les Sulewski | Truist Financial | $16.00 | $12.40 | TheFly | Viatris price target raised to $16 from $15 at Truist |
| October 15, 2025 10:07 am | — | Truist Financial | $15.00 | $9.93 | TheFly | Viatris initiated with a Buy at Truist |
| July 19, 2024 8:05 am | Glen Santangelo | Jefferies | $15.00 | $11.77 | TheFly | Viatris reinstated with a Buy at Jefferies |
| March 28, 2024 6:40 am | David Amsellem | Piper Sandler | $13.00 | $11.83 | StreetInsider | Viatris (VTRS) PT Raised to $13 at Piper Sandler on latest Idorsia deals |
| June 26, 2023 9:08 am | David Amsellem | Piper Sandler | $10.00 | $9.84 | Benzinga | Check Out 3 Health Care Stocks With Over 4% Dividend Yields From Wall Street's Most Accurate Analysts |
| February 1, 2023 8:09 am | — | Barclays | $15.00 | $12.16 | Benzinga | Barclays Maintains Overweight on Viatris, Lowers Price Target to $15 |
| November 9, 2022 4:08 pm | Ashwani Verma | UBS | $12.00 | $10.83 | StreetInsider | UBS Upgrades Viatris (VTRS) to Neutral |
Latest News for VTRS
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Viatris Inc. (VTRS) Q4 2025 Earnings Call Transcript
Total Revenue (Q4 2025): $3.7 billion, up 1% versus prior year, excluding Indore impact.Total Revenue (Full Year 2025): $14.3 billion, up 2% versus prior year,
VTRS beats Q4 estimates on 5% revenue growth, boosted by strong Brands sales and Greater China gains, while returning over $1B to shareholders in 2025.
Viatris (VTRS) came out with quarterly earnings of $0.57 per share, beating the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.54 per share a year ago.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.